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Background Information on
psychiatricmorbidityof prisoners has
almostentirely beenbased onresearch in
Western countries and it is uncertain
whether these research findings are
applicable to other settings.
Aims The primaryobjectivewas to
investigate the prevalence of psychiatric
disorders in Iranianprisoners.
Method Through stratifiedrandom
sampling, 351prisonerswere interviewed
using the clinicalversion of the Structured
Clinical Interview for DSM^IVAxis I
Disorders and the Psychopathy Checklist:
ScreeningVersion.
Results Themajority (88%) of
prisonersmet DSM^IV criteria for
lifetime diagnosis of at leastone Axis I
disorder and 57% were diagnosedwith
current Axis I disorders.Opioid
dependence (73%) had the highest
prevalence amonglifetime diagnoses,
whereasmajordepressive disorder (29%)
was themostcommoncurrentdiagnosis.
Psychopathywasrecorded in 23%.
Prevalence rates of psychiatric disorders
were significantlydifferent amongoffence
categories.
Conclusions Theresults suggestthat a
substantial burden of psychiatric
morbidityexistsintheprisonpopulationof
Iran, withtreatmentchallenges that
appear to be different fromthose
observed in inmates inWestern countries.
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Prison populations are growing rapidly in
Asia. A report has indicated that 87% of
Asian countries have had increasing num-
bers of prisoners over the past decade
(Walmsley, 2003). Despite this, little is
known about non-Western prisoners. A
systematic review in 2002 only found
three papers from non-Western societies,
with a combined sample of 326 prisoners
(Fazel & Danesh, 2002). Although rates
of serious mental illnesses are reliably
known in Western countries, it remains
uncertain whether these findings are
applicable to other countries. In Iran,
the prison population has increased from
about 100 000 in 1993 to 160 000 in
2002, with a rate of 229 inmates per
100 000 of general population. This
puts Iran in the top quartile of the
worldwide incarceration rate per head of
population (Walmsley, 2003). The Iranian
correctional system has several features
in common with other low-income coun-
tries, such as inmate overcrowding and
inadequacy of prison healthcare services
(Andersen, 2004). Our study investigated
the prevalence of mental disorders in a
random sample of Iranian sentenced
prisoners, using standardised diagnostic
instruments.
METHOD
Setting and ethics
The study was conducted from June 2002
to October 2003 in Qasr prison, one
of the largest men’s prisons in Iran,
which housed 9730 inmates in mid-
2002. All participants were informed
that the study was confidential and anon-
ymous, conducted by doctors from outside
the prison, and that participation was
voluntary. The project was conducted
in accordance with the Declaration of
Helsinki as revised in 1996 and was
approved by the ethics committee at
Tehran University of Medical Sciences.
Participants
Prisoners were recruited using stratified
random sampling. The sample was strati-
fied by type of index offence to ensure
adequate representation of all offence
categories. According to official Iranian
statistics, offences are classified into five
categories: violent crimes (murder, kidnap-
ping and armed robbery), non-violent
crimes (such as fraud, pickpocketing and
burglary), drug-related offences (drug use,
possession or trafficking), ‘immoral acts’
(such as fornication, prostitution, and alco-
hol use or trading) and financial crimes
(mainly bounced cheques). People con-
victed of drug-related crimes constitute the
majority (about 50%) of inmates (State
Prisons Organization and Security and
Corrective Measures, 2004). This high pro-
portion reflects the increasing rates of drug
use in the general population. Official
reports indicate that Iran has at least
1 200 000–2 000 000 cases of drug depen-
dency or abuse, constituting 1–2% of the
general population (Mokri, 2002). About
20% of prisoners are sentenced for non-
violent crimes and more than 10% for
violent offences. An additional 10% of
prisoners have been incarcerated for finan-
cial crimes; they are usually individuals
whose financial forecasts have proved
wrong during economic fluctuations (Isla-
mic Republic News Agency, 2001). Prison-
ers with ‘immoral act’ sentences are the
smallest group, constituting 4% of inmates.
Although some drug-related offenders re-
cruited in this study were sentenced primar-
ily for drug smuggling and trading, most of
them also had previous or current sentences
for drug use, which is a criminal offence in
Iran. Offenders from each category were
housed in separate units of Qasr prison.
Preliminary evaluations indicated that these
units had different environments and
should be sampled separately. We used
the current sentence for classifying prison-
ers into the five aforementioned categories.
The sample was composed only of men.
Women generally constitute a small pro-
portion of prisoners in Iran (3.6% in mid-
2002; State Prisons Organisation and
Security and Corrective Measures, 2004).
The study was designed to recruit 80
prisoners from each category, to reach a
total sample size of 400. However, 49
individuals (12%) refused to participate.
Therefore, the final sample consisted of
351 prisoners. The individuals who refused
to participate did not differ from those
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who participated in terms of age (non-
consenters’ mean age 33.1 years,
s.d.¼10.1), level of education (mean 9.4,
s.d.¼4.8 years) and number of previous
prison sentences (mean 1.4, s.d.¼1.8).
Measures
Demographic data were obtained from
official prison records. Prisoners were inter-
viewed using the Clinical Version of the
Structured Clinical Interview for DSM–IV
Axis I Disorders (SCID–CV; First et al,
1997) and the Hare Psychopathy Checklist:
Screening Version (PCL–SV; Hart et al,
1995).
The SCID–CV is a semi-structured in-
terview for making the major DSM–IV
Axis I diagnoses (American Psychiatric
Association, 1994). It has six modules, cov-
ering some 40 psychiatric disorders (First et
al, 1997). The SCID–CV allows assessment
of current and lifetime diagnoses, and has
been used for assessing prevalence rates of
mental disorders in prison populations
(Herrman et al, 1991; Rasmussen et al,
1999; Brink et al, 2001).
The PCL–SV is a 12-item rating scale
and is derived from the Hare Psychopathy
Checklist – Revised (PCL–R; Hart et al,
1995). It is a relatively quick way of asses-
sing psychopathic traits. Its total score can
be used either as a dimensional measure
or for categorical diagnosis. For the first
purpose, the raw total score is used, which
ranges from 0 to 24; for the latter purpose,
a cut-off score of 18 has been recommended
(Hart et al, 1995). The scale is composed of
two factors: factor 1 reveals interpersonal
and affective symptoms of psychopathy,
whereas factor 2 reflects the severity of
social deviance and antisocial lifestyle. Both
factors are scored from 0 to 12. Previous
studies have used the PCL–SV for assessing
psychopathy in offenders (Dolan & Ander-
son, 2003; Ullrich et al, 2003; Hill et al,
2004).
Prisoners were interviewed alone by
one of four interviewers. Each interview
took about 90 min on average. All inter-
viewers were third-year psychiatric trainees
(M.P., O.Y., S.A. and S.V.S.), who went
through a 5-day study-specific training pro-
gramme. In addition, all interviewers had
prior experience with structured diagnostic
interviews and had participated in a study
adapting and validating the SCID–CV in
Iran. Interviewers were regularly supervised
by a board-certified psychiatrist (S.M.A.)
who was trained in the use of the SCID,
and difficult diagnostic issues were resolved
in such meetings.
Statistical analysis
Data were analysed using the Statistical
Package for the Social Sciences, SPSS
version 11.5. As the sample was stratified
by type of offence, all prevalence estimates
were weighted to reflect the actual offence
characteristics of the prison population. The
weights were the inverse of the sampling
fraction in each stratum. Comparisons
between groups were performed by likeli-
hood ratio w2-test and analysis of variance
(ANOVA). All statistical tests were two-
sided and were considered significant at
P50.05.
RESULTS
Demographic and criminological
characteristics
Participants were aged 17–76 years, with a
mean age of 32.7 years. Table 1 sets out
the unweighted socio-demographic and
criminological characteristics of the sam-
ple. Data analyses showed that those
convicted of financial crimes were older,
more educated and more likely to be
married, compared with other inmates.
Multiple previous sentences were less pre-
valent in those imprisoned for financial
and violent offences. However, those con-
victed of violent offences received longer
prison sentences (97.9 months, s.d.¼68.8)
compared with other offender groups
(30.9 months, s.d. 34.4, t(189)¼7.7,
P50.01).
Prevalence of psychiatric disorders
Table 2 lists the current and lifetime preva-
lence rates of Axis I diagnostic categories in
the sample. Current mental disorders were
diagnosed in 57.2% of participants, with
mood disorders having the highest preva-
lence. Of the whole sample, 29.1% met
the diagnostic criteria for major depressive
disorder and 1.5% for dysthymic disorder.
Of those with major depressive disorder,
17.8% met the criteria for mild depressive
episode, 39.6% for moderate episode,
38.5% for severe episode without psychotic
features, and 4.1% for severe episode with
psychotic features. No one met the diagnos-
tic criteria for bipolar disorder. Regarding
psychotic disorders, 2.0% of participants
had schizophrenia, 0.3% delusional dis-
order and 0.8% psychotic disorder not
otherwise specified. Opioids were the prin-
cipal substance of abuse. Current opioid
abuse and dependence were diagnosed in
9.5% of participants; cannabis and seda-
tive, hypnotic or anxiolytic use disorders
were seen in 0.8% and 0.9% respectively.
No one met the diagnostic criteria for
current alcohol abuse or dependence.
Anxiety disorders were diagnosed in 7.7%
of participants, with generalised anxiety
disorder (5.7%) being the most prevalent
diagnosis. Specific phobia, post-traumatic
stress disorder, social phobia and
obsessive–compulsive disorder were diag-
nosed in 1.0%, 0.7%, 0.6% and 0.3%
of participants respectively. Only one pris-
oner with hypochondriasis (0.4%) was
observed. Based on interviewers’ impres-
sions, the current diagnosis of substance
use disorders was thought to be an under-
estimate. Moreover, drugs and alcohol are
generally less available in prison, and cur-
rent rates of substance use disorders in
cross-sectional samples of prisoners will
probably underestimate the true prevalence
(Maden et al, 1994; Fazel et al, 2001;
Andersen, 2004). Thus, we decided to use
the lifetime diagnoses in comparing sub-
groups and estimating the extent of Axis I
disorders comorbidity.
Eighty-eight per cent of prisoners met
DSM–IV lifetime criteria for at least one
Axis I disorder. Substance use disorders
had the highest lifetime prevalence (78%),
followed by mood disorders (48.7%). Life-
time opioid dependence was diagnosed in
72.7% of participants, alcohol dependence
in 8.8% and dependence on other sub-
stances in 0.4%. The lifetime rate of opioid
abuse was 0.1%, alcohol abuse 13.3% and
abuse of other substances 2.4%.
Overall, psychiatric disorders were less
prevalent in the financial offences group.
In addition, offence groups had different
rates of psychiatric morbidity in three out
of the six diagnostic categories: psychotic
disorders, substance use disorders and
anxiety disorders (Table 2).
Comorbidity rates are presented in
Table 3. Substance use disorders were the
main comorbid disorders in diagnostic
categories. Mood disorders were highly
prevalent in participants with anxiety,
substance use and somatoform disorders.
Comorbid anxiety disorders were seen in
a quarter of participants with mood disor-
ders and about half of participants with
somatoform disorders.
According to the data collected in the
overview section of the SCID, only 10.5%
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Table 1 Unweighted demographic and criminological characteristics of the sample
Total sample (n¼351) Type of offence Statistics1,2 P
Non-violent
(n¼71)
Violent
(n¼74)
Drug
(n¼72)
Immoral
(n¼80)
Financial
(n¼54)
Age, years: mean (s.d.) 32.7 (8.9) 31.1 (6.8) 30.2 (6.3) 31.9 (7.4) 31.2 (8.9) 41.2 (11.0) F¼18.2 50.001
Education, years: mean (s.d.) 9.0 (3.9) 7.9 (3.5) 9.0 (4.1) 8.3 (3.2) 8.9 (4.0) 11.5 (4.2) F¼7.9 50.001
Time served in prison, months: mean (s.d.) 14.5 (18.5) 16.3 (22.8) 25.9 (25.1) 6.8 (7.2) 6.3 (6.6) 19.1 (13.3) F¼18.1 50.001
Time until release, months: mean (s.d.) 31.4 (44.3) 18.5 (29.5) 71.5 (60.1) 23.6 (34.2) 15.2 (20.4) 15.4 (23.4) F¼17.9 50.001
Previous sentences, n (%)
None 146 (41.6) 12 (16.9) 50 (67.6) 22 (30.6) 45 (56.2) 17 (31.5) w2¼77.7 50.001
One 90 (25.6) 22 (31.0) 16 (21.6) 15 (20.8) 10 (12.5) 27 (50.0)
Two ormore 115 (32.8) 37 (52.1) 8 (10.8) 35 (48.6) 25 (31.3) 10 (18.5)
Marital status, n (%)
Married 177 (50.4) 29 (40.8) 30 (40.5) 30 (41.7) 40 (50.0) 48 (88.9) w2¼42.9 50.001
Single 133 (37.9) 34 (47.9) 35 (47.3) 30 (41.7) 32 (40.0) 2 (3.7)
Separated/widowed 41 (11.7) 8 (11.3) 9 (12.2) 12 (16.6) 8 (10.0) 4 (7.4)
Birthplace, n (%)
Village 7 (2.0) 5 (7.0) 2 (2.7) 0 (0.0) 0 (0.0) 0 (0.0) w2¼32.6 50.001
Small town 79 (22.5) 19 (26.8) 16 (21.6) 24 (33.3) 16 (20.0) 4 (7.4)
Large city 59 (16.8) 10 (14.1) 16 (21.6) 11 (15.3) 16 (20.0) 6 (11.1)
Capital city (Tehran) 206 (58.7) 37 (52.1) 40 (54.1) 37 (51.4) 48 (60.0) 44 (81.5)
1. Likelihood ratio w2-test and analysis of variance are used for comparing the offence groups.
2. F(4, 345); w2(4, n¼351).
Table 2 Current and lifetime prevalence rates of Axis I diagnostic categories and psychopathy among the sample (total prevalences are weighted, data for offence
groups are unweighted)
Specific disorder Total sample (n¼351) Offence group, n (%)1 w2(4, n¼351) P
Current prevalence %
(95% CI)
Lifetime prevalence %
(95% CI)
Non-violent
(n¼71)
Violent
(n¼74)
Drug
(n¼72)
Immoral
(n¼80)
Financial
(n¼54)
Any Axis I disorder 57.2 (52.0^62.4) 88.4 (85.1^91.9) 65 (91.5) 52 (70.3) 72 (100) 63 (78.8) 29 (53.7) 86.8 50.001
Psychotic disorder 3.1 (1.3^5.0) 3.9 (1.9^6.0) 2 (2.8) 0 (0.0) 4 (5.6) 9 (11.3) 0 (0.0) 10.41 0.03
Mood disorder 30.6 (25.8^35.5) 48.7 (43.2^53.8) 37 (52.1) 41 (55.4) 35 (48.6) 46 (57.5) 19 (35.2) 4.73 0.32
Anxiety disorder 7.7 (4.9^10.5) 15.7 (12.0^19.7) 22 (31.0) 18 (24.3) 5 (6.9) 25 (31.3) 8 (14.8) 25.86 50.001
Substance use disorder 11.2 (7.8^14.5) 78.0 (73.6^82.4) 56 (78.9) 28 (37.8) 72 (100) 52 (65.0) 13 (24.1) 176.43 50.001
Somatoform disorder 0.4 (0.0^1.0) 0.5 (0.0^1.3) 0 (0.0) 2 (2.7) 0 (0.0) 0 (0.0) 1 (1.9) 5.82 0.21
Adjustment disorder 12.6 (9.2^16.1)
Psychopathy 23.5 (19.1^28.1) 16 (22.5) 12 (16.2) 22 (30.6) 12 (15.0) 2 (3.7) 19.63 50.001
1. Likelihood ratio w2-test is used for comparing the offence groups.
Table 3 Comorbidity rates (n¼351; weighted data)
Diagnostic category Comorbidity, % (95% CI)
Psychotic disorder Mood disorder Anxiety disorder Substance use disorder Somatoform disorder Psychopathy
Psychotic disorder 11.2 (0.0^30.4) 6.2 (0.0^20.9) 95.0 (81.8^100) 0.0 (0.0) 19.7 (0.0^43.9)
Mood disorder 0.9 (0.0^2.4) 25.5 (18.9^32.1) 82.5 (76.7^88.3) 0.5 (0.0^1.5) 23.3 (16.9^29.8)
Anxiety disorder 1.5 (0.0^4.9) 77.8 (66.5^89.1) 69.1 (56.5^81.7) 1.9 (0.0^5.6) 8.4 (0.1^15.9)
Substance use disorder 4.8 (2.2^7.4) 51.3 (45.3^57.3) 14.1 (9.9^18.2) 0.0 28.2 (22.8^33.5)
Somatoform disorder 0.0 43.7 (0.0^100) 56.2 (0.0^100) 43.7 (0.0^100) 43.7 (0.0^100)
Psychopathy 3.3 (0.0^7.2) 47.9 (36.9^59.0) 5.7 (0.1^10.8) 93.1 (87.5^98.7) 1.0 (0.0^3.2)
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of prisoners with current Axis I diagnoses
were receiving psychiatric treatment, and
the majority of prisoners with psychiatric
diagnoses (89.5%) did not receive any
psychiatric intervention.
Prevalence of psychopathy
Table 2 shows the prevalence of psycho-
pathy according to the PCL–SV. Using
the standard cut-off score, about a quarter
of prisoners met the criteria for psycho-
pathy. The offence groups were signifi-
cantly different in this regard: those
imprisoned for drug-related offences had
the highest rate of psychopathy, whereas
those imprisoned for financial offences
had the lowest. The same pattern emerged
with both factors of the checklist: the mean
scores for factor 1 and factor 2 were signif-
icantly different between the offence groups
(Table 4).
The majority of participants cate-
gorised as psychopathic (98.8%) had at
least one Axis I disorder, and there was a
significant difference between the psycho-
pathic and non-psychopathic groups in this
regard (w2(1, n¼349)¼9.26, P50.01).
Specifically, rates of substance use
disorders were higher in the psychopathic
group (92.7%) compared with the non-
psychopathic group (73.0%; w2(1, n¼349)¼
16.63, P50.01), whereas rates of anxiety
disorders were lower (6.1% and 19.1%
respectively; w2(1, n¼349)¼9.33, P50.01).
There was no significant difference between
these two groups with regard to the other
diagnostic categories.
Characteristics of prisoners with
psychiatric disorders
Table 5 shows the association between
selected demographic and criminological
characteristics and psychiatric disorders.
Mood disorders and psychopathy were
most prevalent in the youngest age-group,
whereas substance use disorders appeared
to be most prevalent in those aged 25–44
years. Psychotic and substance use disor-
ders were most prevalent among those
with low education. In addition, psychotic
disorders, substance use disorders and
psychopathy were more prevalent in
unmarried prisoners, whereas anxiety dis-
orders were higher in married inmates.
Overall, the prevalence of psychiatric diag-
noses was significantly lower among those
who were born in the capital city of Tehran
than among those born in the provinces.
Finally, prisoners with a history of previous
sentences had significantly higher preva-
lence of psychiatric morbidity compared
with those who did not.
DISCUSSION
To the best of our knowledge, this investi-
gation of 351 Iranian prisoners is the
largest psychiatric study conducted in
non-Western prisons, doubling the com-
bined sample of previous investigations in
low-income countries. The results indicated
that 57% of prisoners in our sample had a
current Axis I disorder. Major depressive
disorder was the most common current
diagnosis and was observed in 29% of
inmates. Psychotic disorders were found in
3%. We found that 88% of prisoners met
DSM–IV criteria for a lifetime diagnosis
of at least one Axis I disorder. Opioid
dependence had the highest prevalence
among lifetime diagnoses and was seen in
three-quarters of prisoners. In addition,
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Table 4 Scores on the Hare Psychopathy Checklist ^ Screening Version
Psychopathy Checklist score: mean (95% CI) F(4, 345) P
Total sample
(n¼351)
Non-violent
offences
(n¼71)
Violent offences
(n¼74)
Drug offences
(n¼72)
Immoral offences
(n¼80)
Financial offences
(n¼54)
Total score 13.4 (12.9^14.0) 13.9 (12.7^15.1) 11.3 (9.5^13.0) 15.6 (15.0^16.2) 11.8 (9.0^14.6) 13.4 (12.9^14.0) 38.78 50.001
Factor 1 3.8 (3.6^4.0) 3.8 (3.3^4.3) 3.0 (2.2^3.7) 4.2 (4.0^4.5) 4.0 (2.7^5.2) 3.8 (3.6^4.0) 7.16 50.001
Factor 2 5.3 (5.1^5.5) 5.2 (4.7^5.7) 4.9 (4.2^5.6) 6.0 (5.8^6.2) 5.3 (4.0^6.7) 5.3 (5.1^5.5) 25.51 50.001
Table 5 Lifetime prevalence rates of Axis I disorders and psychopathy categorised by demographic and criminological characteristics of the sample (n¼351); weighted
data (continued opposite)
Specific disorder Prevalence, % (95% CI)
Age, years Education, years
424 (n¼42) 25^44 (n=269) 545 (n¼40) 512 (n¼226) 12 (n¼79) 412 (n¼46)
Any Axis 1 disorder 77.7 (60.3^95.0) 91.5 (88.2^94.7) 74.1 (59.7^88.4)** 91.5 (88.3^95.3) 90.2 (83.0^96.8) 59.9 (41.7^78.0)**
Psychotic disorder 2.0 (0.0^7.9) 4.6 (2.2^7.1) 0.0 5.6 (2.7^8.5) 0.4 (0.0^2.0) 0.0**
Mood disorder 68.2 (48.7^87.6) 48.9 (42.7^54.4) 35.3 (19.7^51.0)* 48.5 (42.2^55.0) 50.2 (38.9^61.6) 43.1 (24.7^61.4)
Anxiety disorder 12.2 (0.0^25.8) 15.9 (11.7^20.3) 17.2 (4.8^29.6) 15.0 (10.5^19.7) 19.0 (10.0^27.9) 14.3 (1.3^27.2)
Substance use disorder 70.9 (51.9^89.8) 82.6 (78.2^87.1) 48.7 (32.3^65.1)** 83.5 (79.0^88.4) 75.4 (65.6^85.2) 40.4 (22.2^58.6)**
Somatoform disorder 0.0 0.6 (0.0^1.6) 0.0 0.8 (0.0^1.9) 0.0 0.0
Psychopathy 46.8 (26.0^67.6) 23.4 (18.5^28.5) 9.1 (0.0^18.5)** 26.5 (20.9^32.2) 17.7 (9.0^26.4) 15.1 (1.8^28.4)
*P50.05, **P50.01.
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comorbidity was common and substance
use disorders were major comorbid dis-
orders in all diagnostic categories. One
quarter met the criteria for psychopathy
according to the PCL–SV. Finally, offence
groups were significantly different in
terms of demographic characteristics,
prevalence of psychiatric disorders and
estimate of psychopathy.
Comparison with the Iranian
general population
Our results suggest that rates of psychiatric
morbidity in prisoners in Iran are much
higher than in the general population.
Two recent surveys respectively estimated
the prevalence of current psychiatric disor-
ders at 21% and 17% in the general Iranian
population (Mohammadi et al, 2003;
Noorbala et al, 2004), which implies that
the rate of psychiatric morbidity is around
three times higher in prisoners. This finding
is consistent with the results of recent
reviews that the prevalence of psychiatric
disorders in prisoners is higher than in
the general population (Fazel & Danesh,
2002; Andersen, 2004).
Comparison with non-Western
studies
Previous non-Western studies (Fido & al-
Jabally, 1993; Ghubash & El-Rufaie,
1997; Agbahowe et al, 1998) reported
varying rates of psychosis, ranging from
0% to 5%. Regarding depression, Agba-
howe et al (1998) reported two cases of
psychotic depression (2% of prisoners).
The two other studies (Fido & al-Jabally,
1993; Ghubash & El-Rufaie, 1997) found
depression in 13% and 9% of prisoners
respectively – rates lower than that found
in our study. Differences across studies
may be explained by various methodologies
used.
Comparison withWestern studies
Compared with Western countries, the rate
of psychosis is similar in Iranian prisoners,
but rates of depression and substance use
disorders appear to be higher. The review
by Fazel & Danesh found an overall preva-
lence of 3.7% for psychotic illnesses and
10% for major depression among male
prisoners in Western countries (Fazel &
Danesh, 2002). The prevalence of sub-
stance use disorders has been estimated at
between 25% and 50% in most Western
studies (Andersen, 2004). The high rates
found in our investigation suggest that
prison health services have additional chal-
lenges in low-income countries, particularly
where there is a large prison population
related to illegal drug trafficking and use.
Models of effective prison healthcare that
could be used in the Iranian setting need
to incorporate these additional challenges.
We found different prevalences of
psychiatric diagnoses among offence cate-
gories. In particular, financial offenders
had lower rates of psychiatric illness. The
most detailed study of risk factors for pris-
oners found that those convicted of sexual
offences had increased scores for mood
disorders, but did not include a separate
category for those convicted of financial
offences, as the numbers of such inmates
are relatively small in English and Welsh
prisons (Singleton et al, 1998).
Psychopathy
The prevalence rate for psychopathy in Iran
appears to be similar to rates reported in
North American prisoners (25–30%) and
higher than those found in European coun-
tries (Andersen, 2004). There is evidence
that treatment of Axis I disorders in
people with psychopathy is more com-
plicated (Alterman et al, 1998). Therefore,
a high prevalence of psychopathy would
pose additional challenges for psychiatric
services.
Limitations of the study
Our study has a number of limitations. The
participants were recruited from one prison
located in the metropolitan city of Tehran.
However, there is no evidence that the
study prison was different from other Ira-
nian prisons. In addition, the study did
not examine Axis II disorders and therefore
underestimated the extent of comorbidity.
We used the PCL–SV for assessing psy-
chopathy, which has not been validated
for use in the Iranian prison population,
and the findings on its use must be in-
terpreted cautiously. A further limitation
was that although we used the prison’s
criminal and health records to confirm or
deny self-reported statements, some aspects
of PCL–SV scores need more detailed
historical information that we were not
able to corroborate.
Implications for healthcare
The study found that over half of Iranian
prisoners suffered from a treatable mental
disorder, and a third had a current psy-
chotic or major depressive disorder. The
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Table 5 (contd)
Prevalence, % (95% CI)
Marital status Birthplace Previous sentence
Married (n¼177) Notmarried (n¼174) Provinces (n¼145) Capital (n¼206) No (n¼146) Yes (n¼205)
83.5 (77.8^89.2) 93.1 (89.4^96.8)** 92.2 (87.9^96.5) 85.6 (80.7^90.6)* 80.1 (73.3^88.0) 92.3 (88.8^95.7)**
0.7 (0.0^2.0) 6.9 (3.2^10.6)** 3.6 (0.5^6.5) 4.2 (1.4^7.1) 2.5 (0.0 ^5.5) 4.6 (1.9^7.3)
47.2 (39.8^55.1) 49.4 (42.1^56.8) 50.7 (42.7^58.8) 46.7 (39.7^53.8) 42.5 (33.2^51.7) 51.4 (44.9^57.8)
19.8 (13.8^26.1) 12.2 (7.4^17.0)* 18.2 (12.0^24.4) 14.1 (9.1^19.0) 20.3 (12.7^27.8) 13.8 (9.4^18.2)
66.2 (59.3^73.8) 88.4 (83.7^93.1)** 82.8 (76.4^88.6) 74.4 (68.2^80.6) 68.2 (59.4^76.9) 82.7 (77.8^87.6)
0.6 (0.0^1.8) 0.4 (0.0^1.4) 0.9 (0.0^2.4) 0.3 (0.0^1.0) 0.9 (0.0^2.7) 0.4 (0.0^1.1)
17.9 (12.1^23.9) 28.7 (22.1^35.4)* 23.4 (16.6^30.2) 23.7 (17.7^29.7) 27.4 (19.0^35.7) 21.8 (16.4^27.1)
AS SADI E T AL
need for improving psychiatric services in
prison settings is an international public
health burden (Fazel & Danesh, 2002),
and non-Western countries may face
additional challenges in meeting this need.
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CLINICAL IMPLICATIONS
& Themajority of Iranian prisoners had psychiatric disorders; major depressive
disorder was themost common current diagnosis, whereas themost prevalent
lifetime diagnosis was opioid dependence.
& The prisoners were not a homogeneous group.Those incarcerated for financial
crimes appeared to have lower rates of psychiatric morbidity than other offenders.
& The need to improve diagnosis andmanagement of prisoners withmental illness is
a pressing international public health problem.Non-Western countriesmay face
additional challenges in treating these individuals.
LIMITATIONS
& The participants were recruited from a single prison in one country.
& The study did not examine Axis II disorders.
& Wehadno access to detailedprevious psychiatric records or collateral informants.
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